New study validates clotting risk factors in chronic kidney disease

January 17, 2018, Boston University School of Medicine
Credit: CC0 Public Domain

In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) patients from developing thrombosis (blood clots) without causing bleeding complications. They found that boosting a regulatory protein named STUB1 decreased the abundance of tissue factor (TF) and prevented blood vessel blockages in experimental models.

Now, these same researchers have tested other aspect of this hypothesis in humans with promising results. Chronic kidney disease is associated with buildup of urea in the , and leads to accumulation of "uremic" solutes, which was thought to result in cardiovascular toxicity including thrombosis.

Led by BUSM senior author and senior co-author, Vipul Chitalia, MD, PhD, associate professor of medicine, and Katya Ravid, DSc, professor of medicine and biochemistry, an interdisciplinary team expanded their previous study using two independent human cohorts in which blood plasma was analyzed for uremic solutes that are tryptophan byproducts such as indoxyl sulfate (IS) and TF activity, among other tests. Tryptophan is an essential amino acid, meaning the body cannot synthesize it, and must be obtained from the diet.

Using cutting edge machine learning approaches, the researchers analyzed samples from 473 participants of the Dialysis Access Consortium Clopidogrel Prevention of Early AV Fistula Thrombosis trial with advanced CKD, as well as 377 baseline samples from participants in the Thrombolysis in Myocardial Infarction II trial, many of whom had CKD stage 2-3. "Both groups showed an association between blood clotting and the level of IS as well as TF activity. They also found another association between patients who had clots with higher levels of kynurenine, which is another uremic solute found in patients who developed in surgically created passageways between an artery and a vein, known as arteriovenous fistula," explained Chitalia. Overall, this work confirms the effects of uremic solutes in humans and shows that a set of uremic solutes strongly influences thrombosis in patients with different levels of kidney function.

"The translation of findings from to humans can be challenging. However, this human validation of tryptophan metabolites-TF axis supports further studies probing its utility in risk stratification of CKD patients and exploring its role in other diseases with heightened risk of thrombosis." said Ravid.

The study, with Vijaya B. Kolachalama, PhD, assistant professor of medicine, as first author and collaborators such as Anqi Zhang, PhD, instructor of medicine, Jean Francis, MD, assistant professor of medicine and Laura M. Dember, MD, professor of , was published in the Journal of American Society of Nephrology.

Explore further: Understanding a therapeutic paradox for treating thrombo-vascular complications in kidney disease

Related Stories

Understanding a therapeutic paradox for treating thrombo-vascular complications in kidney disease

November 28, 2017
Researchers at Boston University School of Medicine (BUSM) have discovered a potential treatment target to prevent chronic kidney disease patients from developing blood clots without causing bleeding complications - an unwanted ...

Blocking gene expression improves outcomes in blood disease in models

December 1, 2017
Scientists successfully reduced the symptoms of a blood disease called myeloproliferative neoplasm in mouse models by interrupting an important regulatory pathway, according to a Northwestern Medicine study published in the ...

Low levels of circulating protein linked with heart problems in mice with kidney disease

December 4, 2014
Decreased blood levels of a kidney-derived protein called Klotho increases the risk of heart disease in mice with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society ...

Study finds metabolic clues to diabetic kidney failure

January 15, 2014
About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease (ESRD), at which point they require either dialysis or kidney transplantation. Scientists have thought that this ...

Researchers discover key pathway involved in blood vessel occlusion

January 14, 2016
Researchers have made a breakthrough in understanding blood vessel occlusion by discovering a novel pathway involved in this process.

New magnet technology creates easy blood access for hemodialysis patients

June 14, 2017
A new, minimally invasive system which uses radiofrequency energy instead of open surgery to create access for patients needing hemodialysis is reliable, with minimal complications, according to data published in the American ...

Recommended for you

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.